These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 19698865)

  • 1. Renoprotective immunosuppression by pioglitazone with low-dose cyclosporine in rat heart transplantation.
    Tanaka Y; Hasegawa T; Chen Z; Okita Y; Okada K
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):744-51. PubMed ID: 19698865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine dosage can be reduced when used in combination with an anti-intercellular adhesion molecule-1 monoclonal antibody in rats undergoing heterotopic heart transplantation.
    Harrison PC; Mainolfi E; Madwed JB
    J Heart Lung Transplant; 1998 Feb; 17(2):150-7. PubMed ID: 9513853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pioglitazone prevents acute and chronic cardiac allograft rejection.
    Kosuge H; Haraguchi G; Koga N; Maejima Y; Suzuki J; Isobe M
    Circulation; 2006 Jun; 113(22):2613-22. PubMed ID: 16735678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of atorvastatin on chronic allograft nephropathy in rats.
    Zhang W; Liu M; Wu Y; Zhu P; Yin C; Zhang W; Gu M
    J Surg Res; 2007 Dec; 143(2):428-36. PubMed ID: 17628598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-transforming growth factor antibody at low but not high doses limits cyclosporine-mediated nephrotoxicity without altering rat cardiac allograft survival: potential of therapeutic applications.
    Khanna AK; Plummer MS; Hilton G; Pieper GM; Ledbetter S
    Circulation; 2004 Dec; 110(25):3822-9. PubMed ID: 15583082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1 alpha,25-Dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts.
    Redaelli CA; Wagner M; Tien YH; Mazzucchelli L; Stahel PF; Schilling MK; Dufour JF
    Hepatology; 2001 Nov; 34(5):926-34. PubMed ID: 11679963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosiglitazone suppresses cyclosporin-induced chronic transplant dysfunction and prolongs survival of rat cardiac allografts.
    Chen Y; Liu Y; Yuan Z; Tian L; Dallman MJ; Thompson PW; Tam PK; Lamb JR
    Transplantation; 2007 Jun; 83(12):1602-10. PubMed ID: 17589344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leflunomide in experimental transplantation. Control of rejection and alloantibody production, reversal of acute rejection, and interaction with cyclosporine.
    Williams JW; Xiao F; Foster P; Clardy C; McChesney L; Sankary H; Chong AS
    Transplantation; 1994 Apr; 57(8):1223-31. PubMed ID: 8178350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of mono and combination therapy with FTY720 and ICAM-1 mAb for mouse-to-rat cardiac xenotransplantation].
    Xiong HB; Huang ZF; Ye QF; Xia SS
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):41-6. PubMed ID: 17344585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effect of low dose cyclosporine A and human interleukin 10 overexpression on acute rejection in rat lung allotransplantation.
    Pierog J; Gazdhar A; Stammberger U; Gugger M; Hyde S; Mathiesen I; Grodzki T; Schmid RA
    Eur J Cardiothorac Surg; 2005 Jun; 27(6):1030-5. PubMed ID: 15896613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change from cyclosporine to combination therapy of mycophenolic acid with the new sphingosine-1-phosphate receptor agonist, KRP-203, prevents host nephrotoxicity and transplant vasculopathy in rats.
    Fujishiro J; Suzuki C; Kudou S; Yasue T; Hakamata Y; Takahashi M; Murakami T; Hashizume K; Kobayashi E
    J Heart Lung Transplant; 2006 Jul; 25(7):825-33. PubMed ID: 16818126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine treatment of high dose and long duration reduces the severity of graft coronary artery disease in rodent cardiac allografts.
    Lijkwan MA; Cooke DT; Martens JM; Kown MH; Murata S; Peterson SH; Hoyt EG; Robbins RC
    J Heart Lung Transplant; 2005 Apr; 24(4):439-45. PubMed ID: 15797746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pioglitazone preserves vein graft integrity in a rat aortic interposition model.
    Chen Z; Hasegawa T; Tanaka A; Okita Y; Okada K
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):408-416.e1. PubMed ID: 20189191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine mitigates graft coronary artery disease in murine cardiac allografts: description and validation of a novel fully allogeneic model.
    Tanaka M; Mokhtari GK; Balsam LB; Cooke DT; Kofidis T; Zwierzchonievska M; Robbins RC
    J Heart Lung Transplant; 2005 Apr; 24(4):446-53. PubMed ID: 15797747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recipient blood pre-transplant transfusion prolongs hepatic allograft survival in rats.
    Wang FS; Yamaguchi Y; Furuhashi T; Uchino S; Kihara S; Yamada S; Mori K; Ogawa M
    J Surg Res; 2006 Sep; 135(1):52-60. PubMed ID: 16716354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of single-dose rapamycin-based immunosuppression on the development of cardiac allograft vasculopathy.
    Goggins WC; Fisher RA; Cohen DS; Tawes JW; Grimes MM
    J Heart Lung Transplant; 1996 Aug; 15(8):790-5. PubMed ID: 8878761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose cyclosporine treatment fails to prevent coronary luminal narrowing after heart transplantation.
    Vassalli G; Kaski JC; Tousoulis D; Kiowski W; Turina M; Follath F; Gallino A
    J Heart Lung Transplant; 1996 Jun; 15(6):612-9. PubMed ID: 8794036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C. sinensis ablates allograft vasculopathy when used as an adjuvant therapy with cyclosporin A.
    Jordan JL; Hirsch GM; Lee TD
    Transpl Immunol; 2008 Jul; 19(3-4):159-66. PubMed ID: 18619544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibitor cytokine interleukin-1 receptor antagonist synergistically augments cyclosporine immunosuppression in a rat cardiac allograft model.
    Shiraishi M; Csete M; Yasunaga C; McDiarmid SV; Vannice JL; Busuttil RW; Shaked A
    J Surg Res; 1995 May; 58(5):465-70. PubMed ID: 7745957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.